Breast Cancer Study Retracted Due to Duplicated Images

The journal *Cancer Cell International* has retracted a 2015 breast cancer study that claimed cyclin D3 could predict disease-free survival. The retraction, effective October 7, 2026, was issued after duplicated images were found in the migration and invasion assays, compromising the research's reliability. This highlights the importance of research integrity and rigorous peer review.